SLNO logo

Soleno Therapeutics (SLNO) Working capital

annual working capital:

$275.14M+$115.29M(+72.12%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SLNO annual working capital is $275.14 million, with the most recent change of +$115.29 million (+72.12%) on December 31, 2024.
  • During the last 3 years, SLNO annual working capital has risen by +$260.73 million (+1808.72%).
  • SLNO annual working capital is now at all-time high.

Performance

SLNO Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNObalance sheet metrics

quarterly working capital:

$293.18M+$18.04M(+6.56%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SLNO quarterly working capital is $293.18 million, with the most recent change of +$18.04 million (+6.56%) on March 31, 2025.
  • Over the past year, SLNO quarterly working capital has increased by +$155.43 million (+112.82%).
  • SLNO quarterly working capital is now at all-time high.

Performance

SLNO quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNObalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

SLNO Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+72.1%+112.8%
3 y3 years+1808.7%+1193.5%
5 y5 years+1600.5%+3409.1%

SLNO Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+3201.4%at high>+9999.0%
5 y5-yearat high+3201.4%at high>+9999.0%
alltimeall timeat high+2274.2%at high+2239.4%

SLNO Working capital History

DateAnnualQuarterly
Mar 2025
-
$293.18M(+6.6%)
Dec 2024
$275.14M(+72.1%)
$275.14M(+13.1%)
Sep 2024
-
$243.24M(-5.9%)
Jun 2024
-
$258.35M(+87.5%)
Mar 2024
-
$137.76M(-13.8%)
Dec 2023
$159.85M(+1818.1%)
$159.85M(+548.1%)
Sep 2023
-
$24.67M(+110.8%)
Jun 2023
-
$11.70M(+756.5%)
Mar 2023
-
$1.37M(-83.6%)
Dec 2022
$8.33M(-42.2%)
$8.33M(-37.0%)
Sep 2022
-
$13.23M(-25.0%)
Jun 2022
-
$17.64M(-22.2%)
Mar 2022
-
$22.66M(+57.2%)
Dec 2021
$14.41M(-65.4%)
$14.41M(-27.4%)
Sep 2021
-
$19.84M(-24.2%)
Jun 2021
-
$26.18M(-20.7%)
Mar 2021
-
$33.02M(-20.7%)
Dec 2020
$41.63M(+157.3%)
$41.63M(-14.2%)
Sep 2020
-
$48.49M(-11.3%)
Jun 2020
-
$54.64M(+554.0%)
Mar 2020
-
$8.36M(-48.4%)
Dec 2019
$16.18M
$16.18M(+98.4%)
Sep 2019
-
$8.15M(-40.7%)
DateAnnualQuarterly
Jun 2019
-
$13.76M(-26.1%)
Mar 2019
-
$18.61M(-18.3%)
Dec 2018
$22.79M(+40.2%)
$22.79M(+156.0%)
Sep 2018
-
$8.90M(-21.7%)
Jun 2018
-
$11.37M(-18.0%)
Mar 2018
-
$13.87M(-14.7%)
Dec 2017
$16.26M(+676.6%)
$16.26M(+249.0%)
Sep 2017
-
$4.66M(-43.2%)
Jun 2017
-
$8.20M(-14.9%)
Mar 2017
-
$9.63M(+359.8%)
Dec 2016
$2.09M(-34.8%)
$2.09M(-55.7%)
Sep 2016
-
$4.73M(+155.0%)
Jun 2016
-
$1.85M(-62.9%)
Mar 2016
-
$5.00M(+55.8%)
Dec 2015
$3.21M(-54.4%)
$3.21M(-739.8%)
Sep 2015
-
-$502.00K(-90.3%)
Jun 2015
-
-$5.18M(-157.8%)
Mar 2015
-
$8.96M(+27.2%)
Dec 2014
$7.05M(-155.7%)
$7.05M(-646.8%)
Sep 2014
-
-$1.29M(-389.3%)
Jun 2014
-
$445.60K(-103.3%)
Mar 2014
-
-$13.70M(+8.3%)
Dec 2013
-$12.65M(+38.2%)
-$12.65M
Dec 2012
-$9.15M
-

FAQ

  • What is Soleno Therapeutics annual working capital?
  • What is the all time high annual working capital for Soleno Therapeutics?
  • What is Soleno Therapeutics annual working capital year-on-year change?
  • What is Soleno Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly working capital year-on-year change?

What is Soleno Therapeutics annual working capital?

The current annual working capital of SLNO is $275.14M

What is the all time high annual working capital for Soleno Therapeutics?

Soleno Therapeutics all-time high annual working capital is $275.14M

What is Soleno Therapeutics annual working capital year-on-year change?

Over the past year, SLNO annual working capital has changed by +$115.29M (+72.12%)

What is Soleno Therapeutics quarterly working capital?

The current quarterly working capital of SLNO is $293.18M

What is the all time high quarterly working capital for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly working capital is $293.18M

What is Soleno Therapeutics quarterly working capital year-on-year change?

Over the past year, SLNO quarterly working capital has changed by +$155.43M (+112.82%)
On this page